Microbiota in Obesity

Bibliographic Details
Format: Restricted Document
_version_ 1860796920105009152
building INTELEK Repository
collection Online Access
collectionurl https://intelek.unisza.edu.my/intelek/pages/search.php?search=!collection407072
date 2014-12-15 15:15:00
format Restricted Document
id 10686
institution UniSZA
originalfilename 4767-01-FH02-FP-15-02867.pdf
person AH XSL Formatter V6.1 MR4 Lite for Windows (x64) : 6.1.9.14491 (2013/12/19 12:04JST)
recordtype oai_dc
resourceurl https://intelek.unisza.edu.my/intelek/pages/view.php?ref=10686
spelling 10686 https://intelek.unisza.edu.my/intelek/pages/view.php?ref=10686 https://intelek.unisza.edu.my/intelek/pages/search.php?search=!collection407072 Restricted Document Article Journal application/pdf 5 1.6 Adobe Acrobat Pro DC 20 Paper Capture Plug-in AH XSL Formatter V6.1 MR4 Lite for Windows (x64) : 6.1.9.14491 (2013/12/19 12:04JST) 2014-12-15 15:15:00 4767-01-FH02-FP-15-02867.pdf UniSZA Private Access Microbiota in Obesity Interdisciplinary Journal of Microinflammation The obesity epidemic is globally considered as one of the topmost health concern whose multifactorial etiology involves sedentary life style, poor dietary habit, individual’s genetic peculiarity, environmental factors, adipose tissue inflammation and many more. More recently, researchers are intensively focusing on the role of gut microbiome in the manifestation and pathogenesis of obesity and associated complications. Microbiomes modulation of inflammatory responses associated to physiology of obesity implicated the involvement of the Toll-like receptors (TLRs), Short-chain fatty acids (SCFAs) response, gut fermentation mechanisms, as well as passive immune defense exerted by refining of mucous barriers in response to bacterial presence. We reviewhere the role of gut microbiota in the pathogenesis and management of obesity as it relates to metabolic inflammation. Accurate alteration of the gut microbiome appears to be a potential therapeutic intervention that may impede white adipose tissue inflammation and in the long run prevent obesity. 1 2 1-5 http://dx.doi.org/10.4172/ijm.1000118
spellingShingle Microbiota in Obesity
summary The obesity epidemic is globally considered as one of the topmost health concern whose multifactorial etiology involves sedentary life style, poor dietary habit, individual’s genetic peculiarity, environmental factors, adipose tissue inflammation and many more. More recently, researchers are intensively focusing on the role of gut microbiome in the manifestation and pathogenesis of obesity and associated complications. Microbiomes modulation of inflammatory responses associated to physiology of obesity implicated the involvement of the Toll-like receptors (TLRs), Short-chain fatty acids (SCFAs) response, gut fermentation mechanisms, as well as passive immune defense exerted by refining of mucous barriers in response to bacterial presence. We reviewhere the role of gut microbiota in the pathogenesis and management of obesity as it relates to metabolic inflammation. Accurate alteration of the gut microbiome appears to be a potential therapeutic intervention that may impede white adipose tissue inflammation and in the long run prevent obesity.
title Microbiota in Obesity
title_full Microbiota in Obesity
title_fullStr Microbiota in Obesity
title_full_unstemmed Microbiota in Obesity
title_short Microbiota in Obesity
title_sort microbiota in obesity